These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11904849)

  • 1. [Biological markers in epidemiology: concepts, applications, perspectives (part I)].
    Hoffmann W; Latza U; Ahrens W; Greiser KH; Kroke A; Nieters A; Schulze MB; Steiner M; Terschüren C; Wjst M
    Gesundheitswesen; 2002 Feb; 64(2):99-107. PubMed ID: 11904849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological Markers in Epidemiology: Concepts, applications, Perspectives (Part II)].
    Hoffmann W; Latza U; Ahrens W; Greiser KH; Kroke A; Nieters A; Schulze MB; Steiner M; Terschüren C; Wjst M
    Gesundheitswesen; 2002 Mar; 64(3):145-52. PubMed ID: 11904855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projection of molecular epidemiology in medicine.
    Schulte PA
    Gac Med Mex; 1997; 133 Suppl 1():155-9. PubMed ID: 9504119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of metabolic polymorphisms in molecular epidemiological studies: social and ethical implications.
    Hainaut P; Vähäkangas K
    IARC Sci Publ; 1999; (148):395-402. PubMed ID: 10493266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of human populations for early markers of cadmium toxicity: a review.
    Fowler BA
    Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in terrestrial invertebrates for ecotoxicological soil risk assessment.
    Kammenga JE; Dallinger R; Donker MH; Köhler HR; Simonsen V; Triebskorn R; Weeks JM
    Rev Environ Contam Toxicol; 2000; 164():93-147. PubMed ID: 12587835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in the design of molecular and genetic epidemiologic studies.
    Fowke JH
    J Prev Med Public Health; 2009 Nov; 42(6):343-8. PubMed ID: 20009479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxicological significance of biological markers].
    Manno M; Sannolo N
    G Ital Med Lav Ergon; 2004; 26(4):270-7. PubMed ID: 15584434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and application of biomarkers in molecular and genomic epidemiologic research.
    Lee KM; Han S; Park WY; Kang D
    J Prev Med Public Health; 2009 Nov; 42(6):349-55. PubMed ID: 20009480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular epidemiology in occupational medicine: methodological features and impact of individual genetic susceptibility].
    Clonfero E; Ferri GM; Pavanello S
    G Ital Med Lav Ergon; 2003; 25(3):279-84. PubMed ID: 14582238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of biological markers as predictive early-outcome measures in epidemiological research.
    McMichael AJ; Hall AJ
    IARC Sci Publ; 1997; (142):281-9. PubMed ID: 9354927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of biological monitoring in health and epidemiological surveillance: the epidemiological approach].
    Consonni D; Bertazzi PA
    G Ital Med Lav Ergon; 2004; 26(4):334-5. PubMed ID: 15584441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in migraine: their promise, problems, and practical applications.
    Loder E; Rizzoli P
    Headache; 2006; 46(7):1046-58. PubMed ID: 16866709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis.
    Tworoger SS; Hankinson SE
    Cancer Causes Control; 2006 Sep; 17(7):889-99. PubMed ID: 16841256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biologically effective dose biomarkers].
    Miraglia N; Assennato G; Clonfero E; Fustinoni S; Sannolo N
    G Ital Med Lav Ergon; 2004; 26(4):298-301. PubMed ID: 15584436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in the epidemiological analysis and interpretation of intermediate biomarkers.
    Rundle A; Schwartz S
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):491-6. PubMed ID: 12814992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children's exposure to environmental pollutants and biomarkers of genetic damage. I. Overview and critical issues.
    Neri M; Bonassi S; Knudsen LE; Sram RJ; Holland N; Ugolini D; Merlo DF
    Mutat Res; 2006 Jan; 612(1):1-13. PubMed ID: 16002329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.